AC Immune SA
Stock Forecast, Prediction & Price Target
AC Immune SA Financial Estimates
AC Immune SA Revenue Estimates
AC Immune SA EBITDA Estimates
AC Immune SA Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $3.93M 0% | $14.80M 276.13% | Avg: $99.53M Low: $25.34M High: $142.45M avg. 572.48% | Avg: $43.11M Low: $19.62M High: $58.65M avg. -56.68% | Avg: $153.83M Low: $70.02M High: $209.27M avg. 256.79% | Avg: $139.05M Low: $63.30M High: $189.17M avg. -9.60% |
Net Income
% change YoY
| $-72.99M N/A | $-70.75M 3.07% | $-54.23M 23.34% | Avg: $24.48M Low: $-38.29M High: $71.22M avg. 145.15% | Avg: $-37.57M Low: $-71.99M High: $43.73M avg. -253.44% | Avg: $2.99M Low: $873.11K High: $4.39M avg. 107.96% | Avg: $26.27M Low: $7.66M High: $38.59M avg. 778.27% |
EBITDA
% change YoY
| $-70.11M N/A | $-70.77M -0.93% | $-51.83M 26.76% | Avg: $-31.47M Low: $-45.04M High: $-8.01M avg. 39.27% | Avg: $-13.63M Low: $-18.54M High: $-6.20M avg. 56.68% | Avg: $-48.64M Low: $-66.17M High: $-22.14M avg. -256.79% | Avg: $-43.97M Low: $-59.82M High: $-20.01M avg. 9.60% |
EPS
% change YoY
| -$0.97 N/A | -$0.85 12.37% | -$0.64 24.70% | Avg: $0.26 Low: -$0.45 High: $0.84 avg. 140.19% | Avg: -$0.37 Low: -$0.85 High: $0.52 avg. -242.27% | Avg: $0.04 Low: $0.01 High: $0.05 avg. 109.65% | Avg: $0.31 Low: $0.09 High: $0.46 avg. 778.27% |
Operating Expenses
% change YoY
| $79.01M N/A | $74.78M -5.35% | $13.81M -81.52% | Avg: $129.99M Low: $33.09M High: $186.04M avg. 840.70% | Avg: $56.31M Low: $25.63M High: $76.60M avg. -56.68% | Avg: $200.91M Low: $91.46M High: $273.32M avg. 256.79% | Avg: $181.61M Low: $82.67M High: $247.06M avg. -9.60% |
FAQ
What is AC Immune SA stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 194.48% in 2025-2028.
We have gathered data from 3 analysts. Their low estimate is -38.29M, average is 24.48M and high is 71.22M.
What is AC Immune SA stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 190.74% in 2025-2028.
We have gathered data from 3 analysts. Their low revenue estimate is $25.34M, average is $99.53M and high is $142.45M.
What is AC Immune SA stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 196.46% in 2025-2028.
We have gathered data from 3 analysts. Their low earnings per share estimate is -$0.45, average is $0.26 and high is $0.84.
What is the best performing analyst?
In the last twelve months analysts have been covering AC Immune SA stock. The most successful analyst is Thomas Shrader.